Aurinia Pharmaceuticals (AUPH) Change in Acquisitions & Divestments (2020 - 2026)

Aurinia Pharmaceuticals' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $109.0 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 11.41% year-over-year to $109.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $480.1 million (down 10.75% YoY) and the FY2025 annual result came in at $494.1 million, down 15.59% from the prior year.
• Change in Acquisitions & Divestments was $109.0 million for Q1 2026 at Aurinia Pharmaceuticals, down from $145.3 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $170.5 million in Q1 2024 and bottomed at $93.5 million in Q3 2025.
• A 5-year average of $128.4 million and a median of $123.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments jumped 81.43% — and 2025, when it retreated 29.47%.
• Aurinia Pharmaceuticals' Change in Acquisitions & Divestments stood at $118.2 million in 2022, then advanced by 16.82% to $138.1 million in 2023, then fell by 10.22% to $124.0 million in 2024, then gained by 17.25% to $145.3 million in 2025, then retreated by 25.01% to $109.0 million in 2026.
• Business Quant data shows AUPH's Change in Acquisitions & Divestments at $109.0 million in Q1 2026, $145.3 million in Q4 2025, and $93.5 million in Q3 2025.